(Q51721357)

English

Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori.

scientific article published on 25 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

Helicobacter pylori

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J C Delchier

1

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

P Malfertheiner

2

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

R Thieroff-Ekerdt

3

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

language of work or name

0 references

publication date

25 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

40

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

2

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

171-177

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

Helicobacter pylori infection is strongly associated with gastric and duodenal ulcers in a large prospective study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Helicobacter pylori treatment in the era of increasing antibiotic resistance

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Review article: safety of bismuth in the treatment of gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Influence of omeprazole on bioavailability of bismuth following administration of a triple capsule of bismuth biskalcitrate, metronidazole, and tetracycline

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Predicting Helicobacter pylori Eradication

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12808

21 January 2018

Identifiers

10.1111/APT.12808

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24863854

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51721357&oldid=1582825179"